Investments
19Portfolio Exits
6
Want to inform investors similar to Lotus Biosciences about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Lotus Biosciences Investments
19 Investments
Lotus Biosciences has made 19 investments. Their latest investment was in Humanigen as part of their Series D on December 12, 2008.
Lotus Biosciences Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
12/18/2008 | Series D | Humanigen | $32M | No | 2 | |
7/25/2007 | Series C | Humanigen | $20M | No | 1 | |
5/4/2007 | Series D | AVEO Oncology | $53M | Yes | Bessemer Venture Partners, Biogen Idec New Ventures, Flagship Pioneering, GE Capital, Greylock Partners, Highland Capital Partners, Lotus Biosciences, Merlin Biomed Group, Merlin BioSciences, Mitsubishi Corporation Life Sciences Ventures, MPM Capital, Oxford Bioscience Partners, Prospect Venture Partners, Schering-Plough, and Venrock | |
3/15/2006 | Unattributed VC | |||||
8/8/2005 | Unattributed VC - IV |
Date | 12/18/2008 | 7/25/2007 | 5/4/2007 | 3/15/2006 | 8/8/2005 |
|---|---|---|---|---|---|
Round | Series D | Series C | Series D | Unattributed VC | Unattributed VC - IV |
Company | Humanigen | Humanigen | AVEO Oncology | ||
Amount | $32M | $20M | $53M | ||
New? | No | No | Yes | ||
Co-Investors | Bessemer Venture Partners, Biogen Idec New Ventures, Flagship Pioneering, GE Capital, Greylock Partners, Highland Capital Partners, Lotus Biosciences, Merlin Biomed Group, Merlin BioSciences, Mitsubishi Corporation Life Sciences Ventures, MPM Capital, Oxford Bioscience Partners, Prospect Venture Partners, Schering-Plough, and Venrock | ||||
Sources | 2 | 1 |
Lotus Biosciences Portfolio Exits
6 Portfolio Exits
Lotus Biosciences has 6 portfolio exits. Their latest portfolio exit was Humanigen on January 31, 2013.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
